← Leaderboards
Thomas E Adrian
University Of Nebraska Medical Center
$604,809
Attributed
$604,809
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$604,809 · 1
By mechanism
P50$604,809 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Michael A Hollingsworth$34,707,253
- Nora E Sarvetnick$25,892,311
- Kenneth Cowan$25,385,222
- Maneesh Jain$6,905,007
- Amarnath Natarajan$8,497,174
Others in their field
Top investigators on “Bile Obstruction”
- Jorge A. Bezerra · Children'S Hospital Med Ctr (Cincinnati)$12,610,887
- Xiaoming Yang · Johns Hopkins University$5,642,614
- Michael H Nathanson · Yale University$5,440,455
- Gregory M Tiao · Children'S Hospital Med Ctr (Cincinnati)$4,411,341
- Amir Zarrinpar · University Of California, San Diego$4,015,323
- Alexander Miethke · Cincinnati Childrens Hosp Med Ctr$3,308,894
Research focus
Bile ObstructionBlood ChemistryBlood GlucoseCancer ComplicationClinical ResearchDiabetes MellitusEarly DiagnosisHuman Population StudyHuman SubjectInsulinLaboratory RabbitMethod DevelopmentNeoplasm /Cancer DiagnosisPancreas HormonePancreas NeoplasmsPancreatitisPeptide Hormone BiosynthesisProtein PurificationProtein SequenceRadioimmunoassay
Grant awards (3)
AMYLIN AND ITS RELEASING FACTOR IN THE EARLY DIAGNOSIS OF PANCREATIC CANCER$201,603
P50 · FY2002 · CA
AMYLIN AND ITS RELEASING FACTOR IN THE EARLY DIAGNOSIS OF PANCREATIC CANCER$201,603
P50 · FY2001 · CA
AMYLIN AND ITS RELEASING FACTOR IN THE EARLY DIAGNOSIS OF PANCREATIC CANCER$201,603
P50 · FY2000 · CA